0 false false false false false false false false false false true false false true false true false No description of principal activity 2023-08-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 09151250 2023-08-01 2024-07-31 09151250 2024-07-31 09151250 2023-07-31 09151250 2022-08-01 2023-07-31 09151250 2023-07-31 09151250 2022-07-31 09151250 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 09151250 bus:Director1 2023-08-01 2024-07-31 09151250 core:WithinOneYear 2024-07-31 09151250 core:WithinOneYear 2023-07-31 09151250 core:ShareCapital 2024-07-31 09151250 core:ShareCapital 2023-07-31 09151250 core:RevaluationReserve 2024-07-31 09151250 core:RetainedEarningsAccumulatedLosses 2024-07-31 09151250 core:RetainedEarningsAccumulatedLosses 2023-07-31 09151250 bus:SmallEntities 2023-08-01 2024-07-31 09151250 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 09151250 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 09151250 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 09151250 bus:AbridgedAccounts 2023-08-01 2024-07-31
COMPANY REGISTRATION NUMBER: 09151250
Nucleus Advisors Limited
Filleted Unaudited Abridged Financial Statements
31 July 2024
Nucleus Advisors Limited
Abridged Financial Statements
Year ended 31 July 2024
Contents
Page
Report to the board of directors on the preparation of the unaudited statutory abridged financial statements
1
Abridged statement of financial position
2
Notes to the abridged financial statements
4
Nucleus Advisors Limited
Report to the Board of Directors on the Preparation of the Unaudited Statutory Abridged Financial Statements of Nucleus Advisors Limited
Year ended 31 July 2024
As described on the abridged statement of financial position, the directors of the company are responsible for the preparation of the abridged financial statements for the year ended 31 July 2024, which comprise the abridged statement of financial position and the related notes. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions I have compiled these abridged financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
ADK Chartered accountants
Scottsdale House Springfield Avenue Harrogate England HG1 2HR
8 April 2025
Nucleus Advisors Limited
Abridged Statement of Financial Position
31 July 2024
2024
2023
Note
£
£
£
Current assets
Investments
4
126,222
Cash at bank and in hand
10,369
133,166
---------
---------
136,591
133,166
Creditors: amounts falling due within one year
979
913
---------
---------
Net current assets
135,612
132,253
---------
---------
Total assets less current liabilities
135,612
132,253
Provisions
Taxation including deferred tax
1,073
---------
---------
Net assets
134,539
132,253
---------
---------
Capital and reserves
Called up share capital
100
100
Revaluation reserve
3,219
Profit and loss account
131,220
132,153
---------
---------
Shareholders funds
134,539
132,253
---------
---------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged income statement has not been delivered.
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged income statement and the abridged statement of financial position for the year ending 31 July 2024 in accordance with Section 444(2A) of the Companies Act 2006.
Nucleus Advisors Limited
Abridged Statement of Financial Position (continued)
31 July 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 8 April 2025 , and are signed on behalf of the board by:
Mr M Johnson
Director
Company registration number: 09151250
Nucleus Advisors Limited
Notes to the Abridged Financial Statements
Year ended 31 July 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Wallasey, Sully Road, Penarth, South Glamorgan, CF64 2TQ, Wales.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the abridged statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
4. Investments
2024
2023
£
£
Other investments
126,222
---------
----
5. Deferred tax
The deferred tax included in the abridged statement of financial position is as follows:
2024
2023
£
£
Included in provisions
1,073
-------
----
6. Related party transactions
The company was under the joint control of Mr W Birkin & Mr M Johnson throughout the current period. No transactions with related parties were undertaken in the year.